ASX:MDR MedAdvisor (MDR) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free MDR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume719,064 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get MedAdvisor alerts: Email Address Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About MedAdvisor Stock (ASX:MDR)MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia.Read More Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit MDR Stock News HeadlinesMay 9, 2024 | msn.comWhat is the Main Development Region (MDR) of the North Atlantic Ocean?April 30, 2024 | markets.businessinsider.comSophos is a Leader in the IDC MarketScape Report for Worldwide Managed Detection and Response (MDR) 2024 Vendor AssessmentApril 29, 2024 | finance.yahoo.comSmart Blood Analytics Swiss Achieves EU-MDR Certification for VIRUS vs. BACTERIA ModelApril 29, 2024 | tmcnet.comInspira Enterprise Named a Leader in the 2024 IDC MarketScape Report for Worldwide Emerging MDR ServicesApril 26, 2024 | finance.yahoo.comInsiders Rewarded With AU$787k Addition To Investment As MedAdvisor Stock Hits AU$162mApril 10, 2024 | finance.yahoo.comShareholders in MedAdvisor (ASX:MDR) are in the red if they invested five years agoApril 8, 2024 | finanznachrichten.deThreatLocker Inc.: ThreatLocker® Unveils New Managed Detection and Response (MDR) Service with the WorldApril 8, 2024 | finance.yahoo.comThreatLocker® Unveils New Managed Detection and Response (MDR) Service with the WorldMarch 29, 2024 | finance.yahoo.com4 Day Virtual Medical Device Software Compliance Course: Complying with the EU MDR, EU IVDR & FDA RegulationsMarch 21, 2024 | markets.businessinsider.comEQS-News: Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term SupplyMarch 12, 2024 | finance.yahoo.comESET Webinar Outlines How to Outsmart Cybercrime with MDRMarch 12, 2024 | finance.yahoo.comMedical Device Software Course: Complying with the EU MDR, EU IVDR & FDA Regulations - 4 Day Online Event, July 22-25, 2024March 11, 2024 | finance.yahoo.comColdZyme® certified under the new EU medical device regulation (MDR)March 11, 2024 | finance.yahoo.comPulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary InterventionsMarch 11, 2024 | finanznachrichten.deEnzymatica AB: ColdZyme® certified under the new EU medical device regulation (MDR)February 29, 2024 | finance.yahoo.comManaged Detection and Response (MDR) Market Worth $9.5 billion by 2028, Growing At a CAGR of 23.3% Report by MarketsandMarkets™February 27, 2024 | finance.yahoo.comBEN and MedAdvisor Solutions Team Up to Bring Conversational AI to Patients Through PharmaciesFebruary 27, 2024 | finance.yahoo.comThreatHunter.ai Unveils Special Offer for Carbon Black MDR Customers Seeking Swift and Secure MigrationFebruary 8, 2024 | finance.yahoo.comCSOFT Health Sciences Releases MDR White Paper to Support EU Medical Device ComplianceFebruary 8, 2024 | finance.yahoo.comZOLL One of the First to Receive Approval for AEDs Under the EU Medical Device Regulation (MDR) CertificationFebruary 5, 2024 | msn.comHigh risk devices can be exempted from mandatory trials under EU MDRJanuary 24, 2024 | msn.comMDR Commissioner says tax revenues continue to show growthJanuary 22, 2024 | msn.com1MED prepares to unveil EU MDR compliance softwareJanuary 11, 2024 | msn.comHow is Europe’s MedTech industry navigating the EU MDR?January 8, 2024 | finance.yahoo.comInstitutions profited after MedAdvisor Limited's (ASX:MDR) market cap rose AU$41m last week but private companies profited the mostSee More Headlines Receive MDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAdvisor and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:MDR CUSIPN/A CIKN/A Webwww.medadvisor.com.au Phone61 3 9095 3036FaxN/AEmployees31,900Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,030,000.00 Net Margins-8.25% Pretax MarginN/A Return on Equity-15.21% Return on Assets-2.39% Debt Debt-to-Equity Ratio22.65 Current Ratio0.87 Quick Ratio0.47 Sales & Book Value Annual Sales$109.43 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.95 Book ValueA$0.10 per share Price / BookN/AMiscellaneous Outstanding Shares550,160,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.59 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Richard RatliffCEO, MD & DirectorMs. Ancila Desai B.Com.C.A., M.B.A., CFO & Joint Company SecretaryMr. Craig SchnurigerActing Chief Technology OfficerMr. James M. Rotsart R.Ph.Executive VP of US & Client RelationsMr. Wayne MarinoffPresident of ANZMs. Anshu RaghuvanshiJoint Company SecretaryMore ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFArtryaASX:AYAView All CompetitorsInsidersJim XenosSold 6,846,955 sharesTotal: $1.23 M ($0.18/share) This page (ASX:MDR) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAdvisor Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.